How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

All-electric Formula E will adopt a new format for its coming 2026-27 Gen 4 era with its own "ePrix unleashed" version of the shorter-distance sprint races that have proved popular in Formula One and ...